1[1]Mimura K,Shinozawa K,Kobayashi T,et al.Inhibitory effect of -ulinastatin on the aloha-thrombin of factors Ⅴ and Ⅷ.Rinsho Byori,1992,40 (3):317-320.
2[2]Lin SD,Endo R,Sato A,et al.Plasma and urine levels of urinary trypsin inhibitor in patients with acute and fulminant hepatitis.J Gastroenterol Hepatology,2002,17 (2):140-147.
2Cunningham MA,Rondeau E,Chen X,et al.Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis[].The Journal of Experimental Medicine.2000
3Abraham E,Reinhart K,Svoboda P,et al.Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebocontrolled, single - blind, dose escalation study[].Critical Care Medicine.2001
4Szaba FM,Smiley ST.Roles for thrombin and fibrin (ogen) in cytokine chemokine production and macrophage adhesion in vivo[].Blood.2002
5Key NS,Ely EW.Coagulation inhibition for sepsis[].Current Opinion in Hematology.2002
6Bernard GR,Vincent JL,Laterer PF,et al.Efficacy and safety of recombinant human activated protein C for severe sepsis[].The New England Journal of Medicine.2001
7Taylor FB Jr,Stearns-Kurosawa DJ,Kurosawa S,et al.The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis[].Blood.2000
8Napoleone E,Di Santo A,Bastone A,et al.Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells[].Arteriosclerosis and Thrombosis.2002
9Okajima K.Regulation of inflammatory responses by natural anticoagulants[].Immunological Reviews.2001
10Faust SN,Levin M,Harrison OB,et al.Dysfunction of endothelial protein C activation in severe meningococcal sepsis[].The New England Journal of Medicine.2001
